학술논문
Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial.
Document Type
Article
Author
Source
Subject
*THERAPEUTIC use of monoclonal antibodies
*THERAPEUTIC use of antineoplastic agents
*LIVER tumors
*CANCER chemotherapy
*ANTINEOPLASTIC agents
*COLORECTAL cancer
*COMPARATIVE studies
*CANCER patients
*SURVIVAL analysis (Biometry)
*BEVACIZUMAB
*
*
*
*
*
*
*
*
*
Language
ISSN
2072-6694